Logo image of ALCWE.PA

CHARWOOD ENERGY SA (ALCWE.PA) Stock Fundamental Analysis

EPA:ALCWE - Euronext Paris - Matif - FR001400AJ60 - Common Stock - Currency: EUR

3.76  -0.04 (-1.05%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALCWE. ALCWE was compared to 0 industry peers in the Unkown industry. ALCWE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALCWE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALCWE has reported negative net income.
ALCWE had a negative operating cash flow in the past year.
ALCWE.PA Yearly Net Income VS EBIT VS OCF VS FCFALCWE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -1M -2M -3M -4M

1.2 Ratios

Industry RankSector Rank
ROA -17.58%
ROE -31.36%
ROIC N/A
ROA(3y)-0.67%
ROA(5y)N/A
ROE(3y)13.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALCWE.PA Yearly ROA, ROE, ROICALCWE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 20 -20 40 60

1.3 Margins

ALCWE's Gross Margin has improved in the last couple of years.
ALCWE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.92%
GM growth 5YN/A
ALCWE.PA Yearly Profit, Operating, Gross MarginsALCWE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

ALCWE does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALCWE has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for ALCWE is higher compared to a year ago.
ALCWE.PA Yearly Shares OutstandingALCWE.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 1M 2M 3M 4M 5M
ALCWE.PA Yearly Total Debt VS Total AssetsALCWE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M

2.2 Solvency

ALCWE has an Altman-Z score of 1.86. This is not the best score and indicates that ALCWE is in the grey zone with still only limited risk for bankruptcy at the moment.
ALCWE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.86
ROIC/WACCN/A
WACC8.58%
ALCWE.PA Yearly LT Debt VS Equity VS FCFALCWE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M 10M

2.3 Liquidity

ALCWE has a Current Ratio of 2.26. This indicates that ALCWE is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 1.81 indicates that ALCWE should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.26
Quick Ratio 1.81
ALCWE.PA Yearly Current Assets VS Current LiabilitesALCWE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for ALCWE have decreased strongly by -59.36% in the last year.
ALCWE shows a strong growth in Revenue. In the last year, the Revenue has grown by 58.39%.
The Revenue has been growing by 24.07% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-59.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.65%
Revenue 1Y (TTM)58.39%
Revenue growth 3Y24.07%
Revenue growth 5YN/A
Sales Q2Q%56.9%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
ALCWE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 55.52% yearly.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-68.94%
Revenue Next 2Y-23.59%
Revenue Next 3Y17.02%
Revenue Next 5Y55.52%

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALCWE.PA Yearly Revenue VS EstimatesALCWE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
ALCWE.PA Yearly EPS VS EstimatesALCWE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALCWE. In the last year negative earnings were reported.
Also next year ALCWE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCWE.PA Price Earnings VS Forward Price EarningsALCWE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCWE.PA Per share dataALCWE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALCWE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHARWOOD ENERGY SA

EPA:ALCWE (3/7/2025, 7:00:00 PM)

3.76

-0.04 (-1.05%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap19.63M
Analysts86.67
Price Target5.61 (49.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)10%
EPS NY rev (3m)-80%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-21.87%
Revenue NY rev (3m)-41.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.96
P/FCF N/A
P/OCF N/A
P/B 2.76
P/tB 3.44
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS0.95
BVpS1.36
TBVpS1.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.58%
ROE -31.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.1%
FCFM N/A
ROA(3y)-0.67%
ROA(5y)N/A
ROE(3y)13.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.92%
GM growth 5YN/A
F-Score3
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 150.88%
Cap/Sales 23.76%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.26
Quick Ratio 1.81
Altman-Z 1.86
F-Score3
WACC8.58%
ROIC/WACCN/A
Cap/Depr(3y)379.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)27.46%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.65%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)58.39%
Revenue growth 3Y24.07%
Revenue growth 5YN/A
Sales Q2Q%56.9%
Revenue Next Year-68.94%
Revenue Next 2Y-23.59%
Revenue Next 3Y17.02%
Revenue Next 5Y55.52%
EBIT growth 1Y-76.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-333.33%
EBIT Next 3Y81.71%
EBIT Next 5Y181.39%
FCF growth 1Y-2.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.91%
OCF growth 3YN/A
OCF growth 5YN/A